Hormone Replacement Therapy (HRT) for oestrogen deficiency symptoms in post- and peri-menopausal women (see also Section 4.4). The experience of treating women older than 65 years is limited.
Hormone Replacement Therapy (HRT) for oestrogen deficiency symptoms in post- and peri-menopausal women. Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis (see also Section 4.4). The experience of treating women older than 65 years is limited.
The Medicines Company has announced results for its Phase III SOLO clinical trial program of oritavancin, which is under investigation...
AstraZeneca announced positive results from the randomised, double-blinded, placebo-controlled, Phase III SOLO-1 trial of Lynparza (olaparib) tablets. Women with BRCA-mutated...
Sorin Group, a leader in the treatment of cardiovascular diseases, announced that it has received CE (Conformit� Europ�enne) Mark approval...
Sorin Group has received FDA approval for the Solo Smart Aortic Pericardial Heart Valve, for use in patients with Aortic...
Roche announced that it has received CE Mark for its Accu Chek Solo micropump system. The company will initiate the...
AstraZeneca announced positive results from the Phase III SOLO-2 trial designed to determine the efficacy of Lynparza (olaparib) tablets (300mg...
ReCor Medical announced that the RADIANCE-HTN SOLO study with the Paradise renal denervation system met its primary efficacy endpoint and...
Hormone replacement therapy (HRT) for oestrogen deficiency symptoms in post- and peri-menopausal women (see also Section 4.4). The experience of treating women older than 65 years is limited.